Chemotherapy-induced Nausea and Vomiting Drugs Industry Research Business Report 2024: Market to Surpass $5 Billion by 2030 - Antiemetic Drug Formulations, & Quality of Life Focus Drives Demand
December 03, 2024 09:53 ET
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy-induced Nausea and Vomiting Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
Chemotherapy Induced Nausea and Vomiting Drug Pipeline Research 2024 Featuring Helsinn Healthcare, Acacia Pharma, Camurus, Benuvia Therapeutics, Aphios, and Zhuhai Beihai Biotech
June 24, 2024 09:47 ET
|
Research and Markets
Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report...